Product Information
PAROXETINE HCL 40 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1037 per EA under NDC 62135054490. Its NADAC has been published 146 times since Sep 13, 2023.
Strength
40 mg/1
Manufacturer
Chartwell RX LLCNDC
62135054490
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211248On Market Since
11/2/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 40 MG TABLET has been published 146 times since Sep 13, 2023, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1037 per EA |
|---|---|
| All-time high | $0.1313 (Mar 13, 2024) |
| All-time low | $0.0864 (Nov 20, 2024) |
| 52-week high | $0.1134 |
| 52-week low | $0.1037 |
| Median price | $0.1104 |
| Average price | $0.1125 |
| Largest weekly change | +30.0% (Aug 21, 2024) |
| Weeks tracked | 146 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PAROXETINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 40 MG TABLET, manufactured by Chartwell RX LLC, is $0.1037 per EA (NDC 62135054490), effective Jun 24, 2026.
How has the price of PAROXETINE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 40 MG TABLET has declined 17.4%. It has been tracked across 146 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 40 MG TABLET?
Since Sep 13, 2023, the NADAC for PAROXETINE HCL 40 MG TABLET has ranged from a low of $0.0864 (Nov 20, 2024) to a high of $0.1313 (Mar 13, 2024), with a median of $0.1104 per EA.
Are there cheaper alternatives to PAROXETINE HCL 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PAROXETINE HCL 40 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE HCL 40 MG TABLET?
PAROXETINE HCL 40 MG TABLET (NDC 62135054490) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification